Tenecteplase for stroke 4.5 to 6 hours after onset
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests a medicine called tenecteplase (a clot-buster) for people who have a moderate or severe stroke caused by a clot and can be treated 4.5 to 6 hours after symptoms start. It aims to see if this medicine can help improve recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 or older.
- You had a stroke caused by a blood clot, not a bleed.
- Your stroke symptoms started between 4.5 and 6 hours ago.
- Your stroke symptoms are moderate to severe (NIHSS score 4 or higher).
- You have not had a major disability before this stroke.
- You do not have any conditions that make blood-thinning medicine dangerous (like recent bleeding, surgery, or high blood pressure).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a clot-busting drug called tenecteplase for people who have a stroke in the back part of the brain and can be treated later than usual (up to 24 hours after symptoms start). The goal is to see if this drug can help improve recovery.
This study tests a medication called tenecteplase, given before a procedure to remove a large blood clot in the brain. It may help people who have had a severe stroke within the last 4.5 hours.
This trial tests if giving a second dose of a clot-busting drug (tenecteplase) helps people who had a stroke and didn't improve much after the first dose. You must receive the second dose within 4.5 hours of your stroke symptoms starting.
This trial tests if giving a second dose of the clot-busting drug tenecteplase can help people whose stroke symptoms don't improve after the first dose, when a large or medium artery in the brain is still blocked. It may be an option for patients who cannot have a mechanical clot removal procedure.
This trial tests a clot-dissolving medicine called tenecteplase for people who had a stroke more than 4.5 hours ago. It may help you recover if given later than usual.
This trial tests if the clot-busting drug tenecteplase can help people with a moderate to severe stroke when given 24 to 72 hours after symptoms began. It aims to see if this later treatment window can improve recovery and reduce disability.
Hear when a new Stroke, Ischemic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.